Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy. (Q35170258)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy. |
scientific article |
Statements
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy (English)
Dihua Yu
1 reference
Gabriel N Hortobagyi
Eric P Winer
Daniel J Booser
Ian E Krop
Phuong K Morrow
Julia A Moore
Peter R Flores
Yan Xiong
David W Kindelberger
Jeanna Coviello
Aysegul A Sahin
Rodolfo Nuñez